|
1
|
Meyers PA and Gorlick R: Osteosarcoma.
Pediatr Clin North Am. 44:973–989. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Picci P: Osteosarcoma (osteogenic
sarcoma). Orphanet J Rare Dis. 2:62007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harrison DJ, Geller DS, Gill JD, Lewis VO
and Gorlick R: Current and future therapeutic approaches for
osteosarcoma. Expert Rev Anti Infect Ther. 18:39–50. 2017.
View Article : Google Scholar
|
|
5
|
Taft RJ, Pheasant M and Mattick JS: The
relationship between non-protein-coding DNA and eukaryotic
complexity. Bioessays. 29:288–299. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mattick JS: The central role of RNA in
human development and cognition. FEBS Lett. 585:1600–1616. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang JX, Rastetter RH and Wilhelm D:
Non-coding RNAs: An introduction. Adv Exp Med Biol. 886:13–32.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Q, Zhang RW, Sui PC, He HT and Ding
L: Dysregulation of non-coding RNAs in gastric cancer. World
Gastroenterol J. 21:10956–10981. 2015. View Article : Google Scholar
|
|
9
|
Massillo C, Dalton GN, Paula L Farré PL,
De Luca P and De Siervi A: Implications of microRNA dysregulation
in the development of prostate cancer. Reproduction. 154:R81–R97.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song X, Luo X, Gao Q, Wang Y, Gao Q and
Long W: Dysregulation of lncRNAs in; lacenta and pathogenesis of
preeclampsia. Curr Drug Targets. 18:1165–1170. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tan L, Yu JT and Tan L: Causes and
consequences of microRNA dysregulation in neurodegenerative
diseases. Mol Neurobiol. 51:1249–1262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Blackshaw S, Harpavat S, Trimarchi J, Cai
L, Huang H, Kuo WP, Weber G, Lee K, Fraioli RE, Cho SH, et al:
Genomic analysis of mouse retinal development. PLoS Biol.
2:E2472004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dinger ME, Amaral PP, Mercer TR, Pang KC,
Bruce SJ, Gardiner BB, Askarian-Amiri ME, Ru K, Soldà G, Simons C,
et al: Long noncoding RNAs in mouse embryonic stem cell
pluripotency and differentiation. Genome Res. 18:1433–1445. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang H: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pibouin L, Villaudy J, Ferbus D, Muleris
M, Prospéri MT, Remvikos Y and Goubin G: Cloning of the mRNA of
overexpression in colon carcinoma-1: A sequence overexpressed in a
subset of colon carcinomas. Cancer Genet Cytogenet. 133:55–60.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu X, Ravindranath L, Tran N, Petrovics G
and Srivastava S: Regulation of apoptosis by a prostate-specific
and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell
Biol. 25:135–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Calin GA, Liu CG, Ferracin M, Hyslop T,
Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et
al: Ultraconserved regions encoding ncRNAs are altered in human
leukemias and carcinomas. Cancer Cell. 12:215–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luka B, Metka RG and Damjan G: Long
noncoding RNAs as biomarkers in cancer. Dis Markers. 2017:1–14.
2017.
|
|
20
|
Ji J, Tang J, Deng L, Xie Y, Jiang R, Li G
and Sun B: LINC00152 promotes proliferation in hepatocellular
carcinoma by targeting EpCAM via the mTOR signaling pathway.
Oncotarget. 6:42813–42824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Wang X, Tang J, Jiang R, Zhang W, Ji
J and Sun B: HULC and Linc00152 act as novel biomarkers in
predicting diagnosis of hepatocellular carcinoma. Cell Physiol
Biochem. 37:687–696. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou J, Zhi X, Wang L, Wang W, Li Z, Tang
J, Wang J, Zhang Q and Xu Z: Linc00152 promotes proliferation in
gastric cancer through the EGFR-dependent pathway. J Exp Clin
Cancer Res. 34:1352015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Liu J, Bai H, Dang Y, Lv P and Wu
S: Long intergenic non-coding RNA 00152 promotes renal cell
carcinoma progression by epigenetically suppressing P16 and
negatively regulates miR-205. Am J Cancer Res. 7:312–322.
2017.PubMed/NCBI
|
|
24
|
Cai Q, Wang ZQ, Wang SH, Li C, Zhu ZG,
Quan ZW and Zhang WJ: Upregulation of long non-coding RNA LINC00152
by SP1 contributes to gallbladder cancer cell growth and tumor
metastasis via PI3K/AKT pathway. Am J Transl Res. 8:4068–4081.
2016.PubMed/NCBI
|
|
25
|
Teng W, Qiu C, He Z, Wang G, Xue Y and Hui
X: Linc00152 suppresses apoptosis and promotes migration by
sponging miR-4767 in vascular endothelial cells. Oncotarget.
8:85014–85023. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu M, Xue Y, Zheng J, Liu X, Yu H, Liu L,
Li Z and Liu Y: Linc00152 promotes malignant progression of glioma
stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway. Mol
Cancer. 16:1102017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu Z, Dai J, Liao Y, Ma J and Zhou W:
Knockdown of long noncoding RNA LINC0000125 suppresses cellular
proliferation and invasion in glioma cells by regulating MiR-4775.
Oncol Res. 5:857–867. 2017.
|
|
28
|
Bian Z, Zhang J, Li M, Feng Y, Yao S, Song
M, Qi X, Fei B, Yin Y, Hua D and Huang Z: Long non-coding RNA
LINC00152 promotes cell proliferation, metastasis, and confers 5-FU
resistance in colorectal cancer by inhibiting miR-139-5p.
Oncogenesis. 6:3952017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai Q, Wang Z, Wang S, Weng M, Zhou D, Li
C, Wang J, Chen E and Quan Z: Long non-coding RNA LINC00152
promotes gallbladder cancer metastasis and epithelial-mesenchymal
transition by regulating HIF-1α via miR-138. Open Biol.
7:1602472017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu J, Shuang Z, Zhao J, Tang H, Liu P,
Zhang L, Xie X and Xiao X: Linc00152 promotes tumorigenesis by
regulating DNMTs in triple-negative breast cancer. Biomed
Pharmacother. 97:1275–1281. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yuan W, Sun Y, Liu L, Zhou B, Wang S and
Gu D: Circulating lncRNAs serve as diagnostic markers for
hepatocellular carcinoma. Cell Physiol Biochem. 44:125–132. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi
Y and Guo J: Long noncoding RNA associated-competing endogenous
RNAs in gastric cancer. Sci Rep. 4:60882014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun K, Hu P and Xu F: LINC00152/miR-139-5p
regulates gastric cancer cell aerobic glycolysis by targeting
PRKAA1. Biomed Pharmacother. 97:1296–1302. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma P, Wang H, Sun J, Liu H, Zheng C, Zhou
X and Lu Z: LINC00152 promotes cell cycle progression in
hepatocellular carcinoma via miR-193a/b-3p/CCND1 axis. Cell Cycle.
17:974–984. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Militello G, Weirick T, John D, Döring C,
Dimmeler S and Uchida S: Screening and validation of lncRNAs and
circRNAs as miRNA sponges. Brief Bioinform. 1:780–788. 2016.
|
|
36
|
Mets E, Van der Meulen J, Van Peer G,
Boice M, Mestdagh P, Van de Walle I, Lammens T, Goossens S, De
Moerloose B, Benoit Y, et al: MicroRNA-193b-3p acts as a tumor
suppressor by targeting the MYB oncogene in T-cell acute
lymphoblastic leukemia. Leukemia. 29:798–806. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rauhala HE, Jalava SE, Isotalo J, Bracken
H, Lehmusvaara S, Tammela TL, Oja H and Visakorpi T: miR-193b is an
epigenetically regulated putative tumor suppressor in prostate
cancer. Int J Cancer. 127:1363–1372. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gastaldi C, Bertero T, Xu N,
Bourget-Ponzio I, Lebrigand K, Fourre S, Popa A, Cardot-Leccia N,
Meneguzzi G, Sonkoly E, et al: MiR-193b/365a cluster controls
progression of epidermal squamous cell carcinoma. Carcinogenesis.
35:1110–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xie L, Yao Z, Zhang Y, Li D, Hu F, Liao Y,
Zhou L, Zhou Y, Huang Z and He Z: Deep RNA sequencing reveals the
dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma
tumorigenesis and pulmonary metastasis. Cell Death Dis. 9:7722018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang YH, Fu J, Zhang ZJ, Ge CC and Yi Y:
LncRNA-LINC00152 down-regulated by miR-376c-3p restricts viability
and promotes apoptosis of colorectal cancer cells. Am J Transl Res.
8:5286–5297. 2016.PubMed/NCBI
|
